Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $130,406.30 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $125.15, for a total transaction of $130,406.30. Following the completion of the sale, the director now owns 24,672 shares of the company’s stock, valued at approximately $3,087,700.80. This trade represents a 4.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

H Eugene Lockhart also recently made the following trade(s):

• On Monday, December 2nd, H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock. The stock was sold at an average price of $122.81, for a total transaction of $127,968.02.

Huron Consulting Group Stock Performance

Shares of NASDAQ HURN opened at $125.30 on Friday. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The firm’s 50-day moving average price is $124.42 and its two-hundred day moving average price is $115.49. Huron Consulting Group Inc. has a 52-week low of $84.26 and a 52-week high of $133.96. The stock has a market capitalization of $2.22 billion, a P/E ratio of 27.24 and a beta of 0.59.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Benchmark reaffirmed a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Barrington Research increased their target price on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. StockNews.com upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Finally, Wedbush started coverage on Huron Consulting Group in a research note on Monday, February 3rd. They set an “outperform” rating on the stock. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $133.00.

Institutional Trading of Huron Consulting Group

Hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP increased its position in Huron Consulting Group by 29.1% in the third quarter. Wellington Management Group LLP now owns 538,290 shares of the business services provider’s stock worth $58,512,000 after buying an additional 121,371 shares during the period. TI Trust Inc. bought a new position in shares of Huron Consulting Group during the fourth quarter worth about $12,197,000. Franklin Resources Inc. increased its holdings in shares of Huron Consulting Group by 20.5% in the 3rd quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider’s stock worth $42,306,000 after acquiring an additional 67,239 shares during the period. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of Huron Consulting Group during the third quarter valued at approximately $6,336,000. Finally, Jennison Associates LLC raised its stake in Huron Consulting Group by 5.7% during the 3rd quarter. Jennison Associates LLC now owns 574,006 shares of the business services provider’s stock valued at $62,394,000 after acquiring an additional 31,123 shares in the last quarter. Institutional investors own 93.90% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.